SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-257880
Filing Date
2023-10-18
Accepted
2023-10-17 19:25:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d547564dsc13da.htm SC 13D/A 42859
2 EXHIBIT 7 d547564dex997.htm EX-99.7 31035
  Complete submission text file 0001193125-23-257880.txt   75158
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 231330647
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BLVD BRIDGEWATER NJ 08807
Business Address
Patel Gautam (Filed by) CIK: 0001738054 (see all company filings)

Type: SC 13D/A